Insights into the Impact of Microbiota in the Treatment of NAFLD/NASH and Its Potential as a Biomarker for Prognosis and Diagnosis

Non-alcoholic fatty liver disease (NAFLD) is an increasing cause of chronic liver illness associated with obesity and metabolic disorders, such as hypertension, dyslipidemia, or type 2 diabetes mellitus. A more severe type of NAFLD, non-alcoholic steatohepatitis (NASH), is considered an ongoing glob...

Descripción completa

Detalles Bibliográficos
Autores principales: Plaza-Díaz, Julio, Solis-Urra, Patricio, Aragón-Vela, Jerónimo, Rodríguez-Rodríguez, Fernando, Olivares-Arancibia, Jorge, Álvarez-Mercado, Ana I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913217/
https://www.ncbi.nlm.nih.gov/pubmed/33546191
http://dx.doi.org/10.3390/biomedicines9020145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913217/
https://www.ncbi.nlm.nih.gov/pubmed/33546191
http://dx.doi.org/10.3390/biomedicines9020145

Ejemplares similares